뇌졸중의 이차예방 = Secondary Stroke Prevention

참고문헌 (Reference)

1 Mant J, "Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial" 370 : 493-503, 2007

2 Antman EM, "Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association" 115 : 1634-1642, 2007

3 Barter PJ, "Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease" 47 : 492-499, 2006

4 Kerr DJ, "Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer" 357 : 360-369, 2007

5 Wiviott SD, "Prasugrel versus clopidogrel in patients with acute coronary syndromes" 357 : 2001-2015, 2007

6 Jernberg T, "Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease" 27 : 1166-1173, 2006

7 Lincoff AM, "Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials" 298 : 1180-1188, 2007

8 Bhatt DL, "Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial" 49 : 1982-1988, 2007

9 Hart RG, "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation" 146 : 857-867, 2007

10 Singh S, "Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis" 298 : 1189-1195, 2007

11 LaRosa JC, "Intensive lipid lowering with atorvastatin in patients with stable coronary disease" 352 : 1425-1435, 2005

12 Barter P, "HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events" 357 : 1301-1310, 2007

13 Wang X, "Efficacy of folic acid supplementation in stroke prevention: a metaanalysis" 369 : 1876-1882, 2007

14 Barter PJ, "Effects of torcetrapib in patients at high risk for coronary events" 357 : 2109-2122, 2007

15 Nissen SE, "Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes" 356 : 2457-2471, 2007

16 Bhatt DL, "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events" 354 : 1706-1717, 2006

17 Rothwell PM, "Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)" 363 : 1925-1933, 2004

18 Bresalier RS, "Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial" 352 : 1092-1102, 2005